Boyds has a long-standing, trusted relationship with regulatory bodies, facilitating the fast and efficient development of medicinal products and call and gene therapies.
Their expertise has recently been recognised with one of the UK’s most prestigious business awards – The Queen’s Award for Enterprise, International Trade for Outstanding Short Term Growth in overseas sales for the last three years.
They have experience with advanced therapies which may have no obvious precedent. Services include
- Regulatory strategy
- Clinical trial applications (EU, USA)
- Orphan drug applications (EU, USA)
- Marketing authorisation applications (EU, USA)
- Lifecycle management (EU, USA)